These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7340250)

  • 1. [Epidemiologic study on the protective duration of measles vaccine in the Karl-Marx Stadt region].
    Weiss O; Hajduk F; Starke G; Bigl S; Kluge D; Gerike E
    Z Gesamte Hyg; 1981; 27(8):612-3. PubMed ID: 7340250
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiologic and clinical results of measles immunization in the district Karl-Marx-city].
    Hajduk F; Hempel HC
    Dtsch Gesundheitsw; 1968 Dec; 23(52):2483-9. PubMed ID: 5715950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiologic and clinical effect of measles vaccination in Karl-Marx City District. II].
    Hajduk F; Starke G; Grimm J
    Dtsch Gesundheitsw; 1970 Oct; 25(44):2095-6. PubMed ID: 5491297
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of a large-scale field trial with the measles vaccine "L-16 SSW"].
    Seyfert PH; Starke G; Hantsch H
    Dtsch Gesundheitsw; 1967 Nov; 22(47):2243-4. PubMed ID: 5593997
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methodological approaches to the dynamic assessment of the epidemic process in measles during years of vaccine prevention].
    Borovskiĭ IV; Basova LS
    Tr Inst Im Pastera; 1985; 62():58-64. PubMed ID: 3843364
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the incidence of measles in Karl-Marx-Stadt County with special reference to infants].
    Hajduk F; Weiss O; Starke G; Bigl S; Kluge D; Gericke E
    Z Gesamte Hyg; 1980; 26(10):762-4. PubMed ID: 7467502
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiologic situation of measles before the introduction of a vaccination against measles and after 7 years of its use].
    Rozwoda J
    Przegl Epidemiol; 1985; 39(2):273-9. PubMed ID: 4081083
    [No Abstract]   [Full Text] [Related]  

  • 8. [Patient factors in the failure of preventive measles vaccination (epidemiologic observations)].
    Giesecke H
    Padiatr Grenzgeb; 1987; 26(6):447-8. PubMed ID: 3502021
    [No Abstract]   [Full Text] [Related]  

  • 9. Questioning the level of efficacy of the measles vaccine in use in Zimbabwe.
    Marufu T; Siziya S; Manyame B; Xaba E; Silape-Marufu Z; Zimbizi P; Ruwodo C; Mason E; Matchaba-Hove RB; Mudyarabikwa O
    Cent Afr J Med; 1995 Aug; 41(8):241-5. PubMed ID: 7585910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The evolution of measles morbidity and mortality in Romania after the introduction of antimeasles vaccination].
    Cazacu E; Bălan A; Dinică V
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):35-44. PubMed ID: 7981527
    [No Abstract]   [Full Text] [Related]  

  • 11. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 12. [Success and administration of mass immunizations against measles in the district of Halle].
    Grahneis H; Giesecke H; Schlenk B; Spahn E
    Z Gesamte Hyg; 1969 Sep; 15(9):673-80. PubMed ID: 5373004
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic analysis of wild-type measles viruses currently isolated in Turkey.
    Korukluoğlu G; Zarakolu P
    Turk J Pediatr; 2006; 48(2):105-8. PubMed ID: 16848107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV's challenge to measles control.
    Katz SL
    Clin Infect Dis; 2007 Dec; 45(11):1425-6. PubMed ID: 17990223
    [No Abstract]   [Full Text] [Related]  

  • 16. Transmission of measles among a highly vaccinated school population--Anchorage, Alaska, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jan; 47(51-52):1109-11. PubMed ID: 9921727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological characteristics of viral hepatitis in the district of Karl Marx Stadt].
    Hajduk F; Weiss O; Kluge D; Vogel W; Walther S
    Z Arztl Fortbild (Jena); 1979 Feb; 73(4):163-6. PubMed ID: 88821
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serologic studies on the protective duration of measles vaccine].
    Weiss O; Hajduk F; Starke G; Bigl S; Kluge D; Gerike E
    Z Gesamte Hyg; 1981; 27(8):614-5. PubMed ID: 7340251
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of the inadequate consideration of time factors in measles vaccination].
    Lorenz R
    Z Gesamte Hyg; 1972 Jul; 18(7):540-3. PubMed ID: 4641587
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.